Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DIETARY_SUPPLEMENT: omega-3 fatty acid supplement|OTHER: Placebo|OTHER: Clinical assessments|OTHER: Assessment of therapy complications|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Correlative/special studies
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: Cancer and Leukemia Group B